Objective: We aimed to examine whether variability in high-density lipoprotein cholesterol (HDL-c) over time was associated with cognitive function. Method: We conducted a post hoc analysis of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) trial. Our sample included 4,428 participants with at least two repeated HDL-c measures between Months 3 and 24 postbaseline and with cognitive assessments at Month 30. HDL-c variability was defined as the intraindividual standard deviation over each person’s repeated measurements. Results: Higher HDL-c variability was associated with worse performance on the Letter-Digit Coding Test (β [95% confidence interval] [CI] = −4.39 [−7.36, −1.43], p = .004), immediate recall on the 15-Picture Learning Test (β [95% CI] = −0.98 [−1.86, −0.11], p = .027), and delayed recall on the 15-Picture Learning Test (β [95% CI] = −1.90 [−3.14, −0.67], p = .002). The associations did not vary by treatment group. Discussion: Our findings suggest that variability in HDL-c may be associated with poor cognitive function among older adults.
Admiraal-BehloulF.van den HeuvelD. M.OlofsenH.van OschM. J.van der GrondJ.van BuchemM. A.ReiberJ. H. (2005). Fully automatic segmentation of white matter hyperintensities in MR images of the elderly. NeuroImage, 28(3), 607–617. https://doi.org/10.1016/j.neuroimage.2005.06.061
2.
AmarencoP.LabreucheJ.TouboulP. J. (2008). High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review. Atherosclerosis, 196(2), 489–496. https://doi.org/10.1016/j.atherosclerosis.2007.07.033
3.
BennM.NordestgaardB. G.Frikke-SchmidtR.Tybjaerg-HansenA. (2017). Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study. British Medical Journal, 357, Article j1648. https://doi.org/10.1136/bmj.j1648
4.
BeydounM. A.Beason-HeldL. L.Kitner-TrioloM. H.BeydounH. A.FerrucciL.ResnickS. M.ZondermanA. B. (2011). Statins and serum cholesterol’s associations with incident dementia and mild cognitive impairment. Journal of Epidemiology and Community Health, 65(11), 949–957. https://doi.org/10.1136/jech.2009.100826
5.
BoeyE.GayG. M.PohK. K.YeoT. C.TanH. C.LeeC. H. (2016). Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: A 5-year follow-up study. Atherosclerosis, 244, 86–92. https://doi.org/10.1016/j.atherosclerosis.2015.10.110
6.
BrickmanA. M.ReitzC.LuchsingerJ. A.ManlyJ. J.SchupfN.MuraskinJ.. . . MayeuxR. (2010). Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Archives of Neurology, 67(5), 564–569. https://doi.org/10.1001/archneurol.2010.70
7.
BrittonA.Singh-ManouxA.HnatkovaK.MalikM.MarmotM. G.ShipleyM. (2008). The association between heart rate variability and cognitive impairment in middle-aged men and women. The Whitehall II Cohort Study. Neuroepidemiology, 31(2), 115–121. https://doi.org/10.1159/000148257
8.
ChenY.KuH.ZhaoL.WheelerD. C.LiL. C.LiQ.. . . RuanX. Z. (2014). Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(2), 365–376. https://doi.org/10.1161/ATVBAHA.113.301301
9.
ChungH. S.LeeJ. S.KimJ. A.RohE.LeeY. B.HongS. H.. . . ChoiK. M. (2019). Variability in total cholesterol concentration is associated with the risk of dementia: A nationwide population-based cohort study. Frontiers in Neurology, 10, Article 441. https://doi.org/10.3389/fneur.2019.00441
10.
de BruijnR. F.AkoudadS.CremersL. G.HofmanA.NiessenW. J.van der LugtA.. . . IkramM. A. (2014). Determinants, MRI correlates, and prognosis of mild cognitive impairment: The Rotterdam Study. Journal of Alzheimer’s Disease, 42(Suppl. 3), S239–S249. https://doi.org/10.3233/JAD-132558
11.
EliasP. K.EliasM. F.D’AgostinoR. B.SullivanL. M.WolfP. A. (2005). Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosomatic Medicine, 67(1), 24–30. https://doi.org/10.1097/01.psy.0000151745.67285.c2
12.
Emerging Risk Factors Collaboration, Di AngelantonioE.SarwarN.PerryP.KaptogeS.RayK. K.. . . DaneshJ. (2009). Major lipids, apolipoproteins, and risk of vascular disease. Journal of the American Medical Association, 302(18), 1993–2000. https://doi.org/10.1001/jama.2009.1619
13.
GorelickP. B.ScuteriA.BlackS. E.DecarliC.GreenbergS. M.IadecolaC., . . . Council on Cardiovascular Surgery and Anesthesia. (2011). Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 42(9), 2672–2713. https://doi.org/10.1161/STR.0b013e3182299496
14.
HouxP. J.ShepherdJ.BlauwG. J.MurphyM. B.FordI.BollenE. L.. . . WestendorpR. G. (2002). Testing cognitive function in elderly populations: The PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk. Journal of Neurology, Neurosurgery, and Psychiatry, 73(4), 385–389. https://www.ncbi.nlm.nih.gov/pubmed/12235304
15.
IadecolaC.YaffeK.BillerJ.BratzkeL. C.FaraciF. M.GorelickP. B., . . . Stroke Council. (2016). Impact of hypertension on cognitive function: A scientific statement from the American Heart Association. Hypertension, 68(6), e67–e94. https://doi.org/10.1161/HYP.0000000000000053
16.
LeeE. Y.YangY.KimH. S.ChoJ. H.YoonK. H.ChungW. S.. . . ChangK. (2018). Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention. Atherosclerosis, 279, 1–9. https://doi.org/10.1016/j.atherosclerosis.2018.10.012
17.
PatenaudeB.SmithS. M.KennedyD. N.JenkinsonM. (2011). A Bayesian model of shape and appearance for subcortical brain segmentation. NeuroImage, 56(3), 907–922. https://doi.org/10.1016/j.neuroimage.2011.02.046
18.
PendleburyS. T.RothwellP. M. (2009). Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis. The Lancet Neurology, 8(11), 1006–1018. https://doi.org/10.1016/S1474-4422(09)70236-4
19.
PowerM. C.RawlingsA.SharrettA. R.Bandeen-RocheK.CoreshJ.BallantyneC. M.. . . GottesmanR. F. (2018). Association of midlife lipids with 20-year cognitive change: A cohort study. Alzheimer’s & Dementia, 14(2), 167–177. https://doi.org/10.1016/j.jalz.2017.07.757
20.
PowerM. C.WeuveJ.SharrettA. R.BlackerD.GottesmanR. F. (2015). Statins, cognition, and dementia—Systematic review and methodological commentary. Nature Reviews Neurology, 11(4), 220–229. https://doi.org/10.1038/nrneurol.2015.35
21.
PuglielliL.TanziR. E.KovacsD. M. (2003). Alzheimer’s disease: The cholesterol connection. Nature Neuroscience, 6(4), 345–351. https://doi.org/10.1038/nn0403-345
22.
RaffaitinC.FeartC.Le GoffM.AmievaH.HelmerC.AkbaralyT. N.. . . Barberger-GateauP. (2011). Metabolic syndrome and cognitive decline in French elders: The Three-City Study. Neurology, 76(6), 518–525. https://doi.org/10.1212/WNL.0b013e31820b7656
23.
ReisJ. P.LaunerL. J.TerryJ. G.LoriaC. M.ZekiAlHazzouriA.SidneyS.. . . CarrJ. J. (2013). Subclinical atherosclerotic calcification and cognitive functioning in middle-aged adults: The CARDIA study. Atherosclerosis, 231(1), 72–77. https://doi.org/10.1016/j.atherosclerosis.2013.08.038
24.
ReitzC.LuchsingerJ.TangM. X.ManlyJ.MayeuxR. (2005). Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology, 64(8), 1378–1383. https://doi.org/10.1212/01.WNL.0000158274.31318.3C
25.
ReitzC.TangM. X.SchupfN.ManlyJ. J.MayeuxR.LuchsingerJ. A. (2010). Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Archives of Neurology, 67(12), 1491–1497. https://doi.org/10.1001/archneurol.2010.297
26.
RosensonR. S.BrewerH. B.Jr.DavidsonW. S.FayadZ. A.FusterV.GoldsteinJ.. . . Yvan-CharvetL. (2012). Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport. Circulation, 125(15), 1905–1919. https://doi.org/10.1161/CIRCULATIONAHA.111.066589
27.
SabayanB.WijsmanL. W.Foster-DingleyJ. C.StottD. J.FordI.BuckleyB. M.. . . MooijaartS. P. (2013). Association of visit-to-visit variability in blood pressure with cognitive function in old age: Prospective cohort study. British Medical Journal, 347, Article f4600. https://doi.org/10.1136/bmj.f4600
28.
ShepherdJ.BlauwG. J.MurphyM. B.CobbeS. M.BollenE. L.BuckleyB. M.. . . StottD. J. (1999). The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. The American Journal of Cardiology, 84(10), 1192–1197. https://www.ncbi.nlm.nih.gov/pubmed/10569329
29.
SmitR. A. J.JukemaJ. W.PostmusI.FordI.SlagboomP. E.HeijmansB. T.. . . TrompetS. (2018). Visit-to-visit lipid variability: Clinical significance, effects of lipid-lowering treatment, and (pharmaco) genetics. Journal of Clinical Lipidology, 12(2), 266–276.e3. https://doi.org/10.1016/j.jacl.2018.01.001
30.
SmitR. A. J.TrompetS.SabayanB.le CessieS.van der GrondJ.van BuchemM. A.. . .JukemaJ. W. (2016). Higher visit-to-visit low-density lipoprotein cholesterol variability is associated with lower cognitive performance, lower cerebral blood flow, and greater white matter hyperintensity load in older subjects. Circulation, 134(3), 212–221. https://doi.org/10.1161/CIRCULATIONAHA.115.020627
31.
SmithS. M.JenkinsonM.WoolrichM. W.BeckmannC. F.BehrensT. E.Johansen-BergH.. . . MatthewsP. M. (2004). Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage, 23(Suppl. 1), S208–S219. https://doi.org/10.1016/j.neuroimage.2004.07.051
32.
ten DamV. H.BoxF. M.de CraenA. J.van den HeuvelD. M.BollenE. L.MurrayH. M.. . . GroupP. S. (2005). Lack of effect of pravastatin on cerebral blood flow or parenchymal volume loss in elderly at risk for vascular disease. Stroke, 36(8), 1633–1636. https://doi.org/10.1161/01.STR.0000173162.88600.29
33.
van der WulpM. Y.VerkadeH. J.GroenA. K. (2013). Regulation of cholesterol homeostasis. Molecular and Cellular Endocrinology, 368(1–2), 1–16. https://doi.org/10.1016/j.mce.2012.06.007
34.
VergeerM.HolleboomA. G.KasteleinJ. J.KuivenhovenJ. A. (2010). The HDL hypothesis: Does high-density lipoprotein protect from atherosclerosis?Journal of Lipid Research, 51(8), 2058–2073. https://doi.org/10.1194/jlr.R001610
35.
VoightB. F.PelosoG. M.Orho-MelanderM.Frikke-SchmidtR.BarbalicM.JensenM. K.. . . KathiresanS. (2012). Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study. The Lancet, 380(9841), 572–580. https://doi.org/10.1016/S0140-6736(12)60312-2
36.
WarstadtN. M.DennisE. L.JahanshadN.KohannimO.NirT. M.McMahonK. L., . . . Alzheimer’s Disease Neuroimaging Initiative. (2014). Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructure. Neurobiology of Aging, 35(11), 2504–2513. https://doi.org/10.1016/j.neurobiolaging.2014.05.024
37.
YanoY.NingH.AllenN.ReisJ. P.LaunerL. J.LiuK.. . . Lloyd-JonesD. M. (2014). Long-term blood pressure variability throughout young adulthood and cognitive function in midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) study. Hypertension, 64(5), 983–988. https://doi.org/10.1161/HYPERTENSIONAHA.114.03978
38.
Zeki Al HazzouriA.ElfassyT.CarnethonM. R.Lloyd-JonesD. M.YaffeK. (2017). Heart rate variability and cognitive function in middle-age adults: The coronary artery risk development in young adults. American Journal of Hypertension, 31(1), 27–34. https://doi.org/10.1093/ajh/hpx125
39.
Zeki Al HazzouriA.HaanM. N.DengY.NeuhausJ.YaffeK. (2014). Reduced heart rate variability is associated with worse cognitive performance in elderly Mexican Americans. Hypertension, 63(1), 181–187. https://doi.org/10.1161/HYPERTENSIONAHA.113.01888
40.
Zeki Al HazzouriA.VittinghoffE.SidneyS.ReisJ. P.JacobsD. R.Jr.YaffeK. (2015). Intima-media thickness and cognitive function in stroke-free middle-aged adults: Findings from the coronary artery risk development in young adults study. Stroke, 46(8), 2190–2196. https://doi.org/10.1161/STROKEAHA.115.008994
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
